157 related articles for article (PubMed ID: 30486609)
1. CD56 and CD11b Positivity with Low Smac/DIABLO Expression as Predictors of Chemoresistance in Acute Myeloid Leukaemia: Flow Cytometric Analysis.
Ibrahim A; Zahran AM; Aly SS; Refaat A; Hassan MH
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3187-3192. PubMed ID: 30486609
[TBL] [Abstract][Full Text] [Related]
2. Influence of high expression of Smac/DIABLO protein on the clinical outcome in acute myeloid leukemia patients.
Pluta A; Wrzesien-Kus A; Cebula-Obrzut B; Wolska A; Szmigielska-Kaplon A; Czemerska M; Pluta P; Robak T; Smolewski P; Wierzbowska A
Leuk Res; 2010 Oct; 34(10):1308-13. PubMed ID: 20061022
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of second mitochondria-derived activator of caspase (Smac/DIABLO) expression in bladder cancer and target for therapy.
Mizutani Y; Katsuoka Y; Bonavida B
Int J Oncol; 2010 Aug; 37(2):503-8. PubMed ID: 20596678
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Bcl2 protein predicts chemoresistance in acute myeloid leukemia: its correlation with FLT3.
Mehta SV; Shukla SN; Vora HH
Neoplasma; 2013; 60(6):666-75. PubMed ID: 23906301
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia.
Djunic I; Virijevic M; Djurasinovic V; Novkovic A; Colovic N; Kraguljac-Kurtovic N; Vidovic A; Suvajdzic-Vukovic N; Tomin D
Med Oncol; 2012 Sep; 29(3):2077-82. PubMed ID: 22081445
[TBL] [Abstract][Full Text] [Related]
6. The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0.
Suzuki R; Ohtake S; Takeuchi J; Nagai M; Kodera Y; Hamaguchi M; Miyawaki S; Karasuno T; Shimodaira S; Ohno R; Nakamura S; Naoe T
Int J Hematol; 2010 Mar; 91(2):303-9. PubMed ID: 20111912
[TBL] [Abstract][Full Text] [Related]
7. Correlation of CD11b and CD56 expression in adult acute myeloid leukemia with cytogenetic risk groups and prognosis.
Juncà J; Garcia-Caro M; Granada I; Rodríguez-Hernández I; Torrent A; Morgades M; Ribera JM; Millá F; Feliu E
Ann Hematol; 2014 Sep; 93(9):1483-9. PubMed ID: 24782118
[TBL] [Abstract][Full Text] [Related]
8. The importance of CD7 and CD56 antigens in acute leukaemias.
Tiftik N; Bolaman Z; Batun S; Ayyildiz O; Isikdogan A; Kadikoylu G; Muftuoglu E
Int J Clin Pract; 2004 Feb; 58(2):149-52. PubMed ID: 15055863
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Parameters of Acute Myeloid Leukaemia at Presentation.
Jahic A; Iljazovic E; Hasic S; Arnautovic AC; Sabitovic D; Mesanovic S; Sahovic H; Simendic V
Med Arch; 2017 Feb; 71(1):20-24. PubMed ID: 28428668
[TBL] [Abstract][Full Text] [Related]
10. [Clinical Features and Prognosis of 227 cases of Acute Myeloid Leukemia with Cross-lineage Antigen Expression].
Fang F; Zhu P; Zhang Y; Lu XZ; Dong YJ; Sun YH; Wang LH; Bu DF; Cen XN; Wang MJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):990-7. PubMed ID: 27531762
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of CD11b Expression Level for Acute Myeloid Leukemia Patients: A Meta-Analysis.
Xu S; Li X; Zhang J; Chen J
PLoS One; 2015; 10(8):e0135981. PubMed ID: 26309131
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Smac/DIABLO protein expression with the clinico-pathological features of breast cancer patients.
Pluta P; Cebula-Obrzut B; Ehemann V; Pluta A; Wierzbowska A; Piekarski J; Bilski A; Nejc D; Kordek R; Robak T; Smolewski P; Jeziorski A
Neoplasma; 2011; 58(5):430-5. PubMed ID: 21744997
[TBL] [Abstract][Full Text] [Related]
13. Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation.
Yang DH; Lee JJ; Mun YC; Shin HJ; Kim YK; Cho SH; Chung IJ; Seong CM; Kim HJ
Am J Hematol; 2007 Jan; 82(1):1-5. PubMed ID: 16986129
[TBL] [Abstract][Full Text] [Related]
14. CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21).
Iriyama N; Hatta Y; Takeuchi J; Ogawa Y; Ohtake S; Sakura T; Mitani K; Ishida F; Takahashi M; Maeda T; Izumi T; Sakamaki H; Miyawaki S; Honda S; Miyazaki Y; Taki T; Taniwaki M; Naoe T
Leuk Res; 2013 Sep; 37(9):1021-6. PubMed ID: 23810283
[TBL] [Abstract][Full Text] [Related]
15. [Immunophenotypic Analysis of Patients with CD56⁺ Acute Myeloid Leukemia].
Guo R; Shen AL; Wang Y; Liu L; Zhang JF; Wang R; Li JY; Wu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1231-4. PubMed ID: 26524014
[TBL] [Abstract][Full Text] [Related]
16. Clonal selection of CD56+ t(8;21) AML blasts: further suggestion of the adverse clinical significance of this biological marker?
Daniels JT; Davis BJ; Houde-McGrail L; Byrd JC
Br J Haematol; 1999 Nov; 107(2):381-3. PubMed ID: 10583228
[TBL] [Abstract][Full Text] [Related]
17. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
18. HAG regimen improves survival in adult patients with hypocellular acute myeloid leukemia.
Hu X; Fu W; Wang L; Gao L; Lü S; Xi H; Qiu H; Chen L; Chen J; Ni X; Xu X; Zhang W; Yang J; Wang J; Song X
Oncotarget; 2016 Jan; 7(3):3623-34. PubMed ID: 26497216
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of CD200 and CD56 Expression in Patients with Acute Myeloid Leukemia.
Aref S; Abousamra N; El-Helaly E; Mabed M
Asian Pac J Cancer Prev; 2020 Mar; 21(3):743-748. PubMed ID: 32212802
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation.
Jiang A; Jiang H; Brandwein J; Kamel-Reid S; Chang H
Leuk Res; 2011 Apr; 35(4):492-8. PubMed ID: 20684989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]